Literature DB >> 22605835

Complication of etanercept treatment for rheumatoid arthritis--purulent pericarditis caused by a commensal organism.

Gemma K Taylor1, Louise Elliott, Michael D Sosin, Shiu Shing Soo.   

Abstract

The patient presented with increasing fatigue and dyspnoea. The patient had medical history of rheumatoid arthritis for which she had been taking methotrexate for the past 15 years and etanercept for the past 6 years. Initial diagnosis was cardiac failure but further investigation by echocardiogram revealed a large pericardial effusion. Empirical piperacillin-tazobactam was started due to moderately raised inflammatory markers. Four hundred millilitre of frank pus was aspirated from the pericardial sac and antimicrobial treatment was changed to meropenem. Gram positive cocci were seen in the initial Gram stain, but conventional cultures remained negative. However, 16S ribosomal RNA gene sequencing of the pus sample detected the presence of Parvimonas micra genome. Reaccumulation of the effusion required further drainage where again P micra was detected by 16S ribosomal RNA gene sequencing. Two weeks of meropenem was completed followed by treatment with benzylpenicillin and metronidazole.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605835      PMCID: PMC3351623          DOI: 10.1136/bcr.01.2012.5644

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Peptostreptococcal pericarditis complicating anti-tumour necrosis factor alpha treatment in rheumatoid arthritis.

Authors:  S Harney; F D O'Shea; O FitzGerald
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  Pericarditis as a complication of infliximab therapy in Crohn's disease.

Authors:  J P Burke; B Kelleher; S Ramadan; M Quinlan; D Sugrue; M A O'Donovan
Journal:  Inflamm Bowel Dis       Date:  2008-03       Impact factor: 5.325

3.  Anti-TNF treatment and miliary tuberculosis in Crohn's disease.

Authors:  Branislava Milenković; Aleksandra Dudvarski-Ilić; Goran Janković; Lena Martinović; Dragana Mijac
Journal:  Srp Arh Celok Lek       Date:  2011 Jul-Aug       Impact factor: 0.207

4.  Granulomatous salmonella osteomyelitis associated with anti-tumor necrosis factor therapy in a non-sickle cell patient: a case report.

Authors:  Elaine S Gould; Anthony G Gilet; Vincent J Vigorita
Journal:  Skeletal Radiol       Date:  2010-02-21       Impact factor: 2.199

5.  Effusive-constrictive pericarditis.

Authors:  Jaume Sagristà-Sauleda; Juan Angel; Antonio Sánchez; Gaietà Permanyer-Miralda; Jordi Soler-Soler
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

6.  Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Authors:  A Strangfeld; M Eveslage; M Schneider; H J Bergerhausen; T Klopsch; A Zink; J Listing
Journal:  Ann Rheum Dis       Date:  2011-07-25       Impact factor: 19.103

  6 in total
  3 in total

1.  Bacteraemia due to Parvimonas micra, a commensal pathogen, in a patient with an oesophageal tumour.

Authors:  Rafael García Carretero; Esther Luna-Heredia; Monica Olid-Velilla; Oscar Vazquez-Gomez
Journal:  BMJ Case Rep       Date:  2016-11-18

2.  Molecular diagnosis of opportunistic pericardial infection in a patient treated with adalimumab: the role of next-generation sequencing.

Authors:  Stefano Poli; Manola Comar; Roberto Luzzati; Gianfranco Sinagra
Journal:  BMJ Case Rep       Date:  2016-08-29

3.  Hemorrhagic Pericardial Effusion with Tamponade: A Rare Adverse Effect of Infliximab-Case Report and Literature Review.

Authors:  Henry D Lather; J Michelle Kahlenberg
Journal:  Case Rep Rheumatol       Date:  2016-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.